Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3031 AL 3045

Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics

Paul D, Chipurupalli S, Justin A, Raja K, Mohankumar SK.

J Pharmacol Toxicol Methods. 2020 Nov-Dec;106:106932. doi: 10.1016/j.vascn.2020.106932. Epub 2020 Oct 20.

Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease

Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C.

Neuron. 2020 Dec 9;108(5):801-821. doi: 10.1016/j.neuron.2020.09.029. Epub 2020 Oct 22.

Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease

Manek E, Darvas F, Petroianu GA.

Molecules. 2020 Oct 21;25(20):4866. doi: 10.3390/molecules25204866.

Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism

Xing S, Li Q, Xiong B, Chen Y, Feng F, Liu W, Sun H.

Med Res Rev. 2021 Mar;41(2):858-901. doi: 10.1002/med.21745. Epub 2020 Oct 25.

Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives

Sun BL, Chen Y, Fan DY, Zhu C, Zeng F, Wang YJ.

Sci China Life Sci. 2021 Jun;64(6):926-937. doi: 10.1007/s11427-020-1810-y. Epub 2020 Oct 23.

Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease

Gleason A, Bush AI.

Neurotherapeutics. 2021 Jan;18(1):252-264. doi: 10.1007/s13311-020-00954-y. Epub 2020 Oct 27.

Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review

Fakhri S, Pesce M, Patruno A, Moradi SZ, Iranpanah A, Farzaei MH, Sobarzo-Sánchez E.

Molecules. 2020 Oct 24;25(21):4926. doi: 10.3390/molecules25214926.

Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression

Noguchi-Shinohara M, Ono K, Hamaguchi T, Nagai T, Kobayashi S, Komatsu J, Samuraki-Yokohama M, Iwasa K, Yokoyama K, Nakamura H, Yamada M.

Sci Rep. 2020 Oct 29;10(1):18627. doi: 10.1038/s41598-020-73729-2.

Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance

Wang L, Bharti, Kumar R, Pavlov PF, Winblad B.

Eur J Med Chem. 2021 Jan 1;209:112915. doi: 10.1016/j.ejmech.2020.112915. Epub 2020 Oct 15.

Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy

Zhang W, Feng C, Jiang H.

Ageing Res Rev. 2021 Jan;65:101207. doi: 10.1016/j.arr.2020.101207. Epub 2020 Nov 1.

Nrf2: a dark horse in Alzheimer's disease treatment

Osama A, Zhang J, Yao J, Yao X, Fang J.

Ageing Res Rev. 2020 Dec;64:101206. doi: 10.1016/j.arr.2020.101206. Epub 2020 Nov 2.

Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis

Li X, Xuan W, Chen D, Gao H, Wang G, Guo Q, Wang Y, Song H, Cai B.

J Alzheimers Dis. 2020;78(4):1315-1338. doi: 10.3233/JAD-200770.

Antimicrobial therapy and the potential mechanisms in Alzheimer's disease

Song X, Chen J, Hou Z, Xie N.

Neurosci Lett. 2021 Jan 10;741:135464. doi: 10.1016/j.neulet.2020.135464. Epub 2020 Nov 6.

Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease

Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C.

Life Sci. 2021 Jan 1;264:118627. doi: 10.1016/j.lfs.2020.118627. Epub 2020 Oct 22.

Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

Bautista-Aguilera ÓM, Ismaili L, Iriepa I, Diez-Iriepa D, Chabchoub F, Marco-Contelles J, Pérez M.

Chem Rec. 2021 Jan;21(1):162-174. doi: 10.1002/tcr.202000107. Epub 2020 Nov 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias